Viewing Study NCT04231292


Ignite Creation Date: 2025-12-24 @ 3:51 PM
Ignite Modification Date: 2025-12-24 @ 3:51 PM
Study NCT ID: NCT04231292
Status: UNKNOWN
Last Update Posted: 2020-01-18
First Post: 2020-01-14
Is Possible Gene Therapy: False
Has Adverse Events: False

Brief Title: A Phase 2 Clinical Study of Pegerythropoietin Injection (RD01) for the Treatment of Anemia in Chronic Renal Failure Patients With Hemodialysis
Sponsor: Shengzhen Sciprogen Bio-pharmaceutical Co. Ltd
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module